Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform
VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership
01:25pm, Wednesday, 13'th May 2026
Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
09:02am, Wednesday, 06'th May 2026
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises
02:21am, Wednesday, 06'th May 2026
Medical products maker Smith+Nephew posted a 3.1% rise in first-quarter underlying revenue on Wednesday, helped by strong sports medicine and wound management performance, a
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming Europ
SNN vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th May 2026
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value oppo
SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study
11:40am, Friday, 24'th Apr 2026
Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.
Deprince Race & Zollo Inc. Purchases 36,072 Shares of Smith & Nephew SNATS, Inc. $SNN
04:30am, Tuesday, 14'th Apr 2026
Deprince Race and Zollo Inc. increased its position in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) by 10.6% in the undefined quarter, according to the company in its most recent 13F filing with
Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair SmithNephew (LSE: SN, NYSE: SNN), the global medical technology company, today a
Barrow Hanley Mewhinney & Strauss LLC Sells 256,112 Shares of Smith & Nephew SNATS, Inc. $SNN
04:02am, Thursday, 12'th Mar 2026
Barrow Hanley Mewhinney and Strauss LLC cut its position in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) by 30.6% during the undefined quarter, according to the company in its most recent Form 1
SNN Launches ALLEVYN COMPLETE CARE Dressing for Wound Management
01:15pm, Wednesday, 11'th Mar 2026
Smith + Nephew launches ALLEVYN COMPLETE CARE foam dressing for wound management, expanding its Advanced Wound Management portfolio.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance back
Smith & Nephew SNATS Q4 Earnings Call Highlights
01:34am, Wednesday, 04'th Mar 2026
Smith and Nephew SNATS (NYSE: SNN) executives struck an optimistic tone in the company's fourth-quarter and full-year 2025 results presentation, pointing to a "strong finish" that landed at the high e
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
01:00pm, Tuesday, 03'rd Mar 2026
Smith+Nephew announces it will feature handheld robotics during the American Academy of Orthopedic Surgeons (AAOS) Annual meeting in New Orleans this week.
Uniting the most advanced technologies for biomechanical repair and biological augmentation Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase i
